Skip to main content

GOLDMAN SACHS GROUP INC

Position in UNCY — Unicycive Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in UNCY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$681,475
+$503,204 QoQ
Shares Held
145,304
+436.3% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 80 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UNCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. UNCY ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in UNCY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $681,475 145,304
2026-03-31 $178,271 27,093
2025-09-30 $197,072 45,200
2025-03-31 $42,248 73,475
2024-12-31 $58,444 73,608
2024-09-30 $38,116 93,424
2024-06-30 $46,769 93,352
2024-03-31 $128,807 93,339
2023-12-31 $81,022 93,344
2023-09-30 $80,180 93,233
2023-06-30 $122,791 95,931